AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Hologic Inc. (HOLX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

64.06

0.82 (1.30%)

At close: Feb 18, 2025, 3:59 PM

63.93

-0.20%

After-hours: Feb 18, 2025, 04:11 PM EST

undefined% (undefined)

Bid	62.77
Market Cap	14.37B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	3.16
PE Ratio (ttm)	20.27
Forward PE	n/a
Analyst	Hold

Ask	65.15
Volume	1,401,903
Avg. Volume (20D)	2,406,267
Open	62.93
Previous Close	63.24
Day's Range	62.70 - 64.40
52-Week Range	62.70 - 84.67
Beta	undefined

About HOLX

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima vi...

[Show more]

Industry Medical - Instruments & Supplies

Sector Healthcare

IPO Date Mar 1, 1990

Employees 7,063

Stock Exchange NASDAQ

Ticker Symbol HOLX

Website https://www.hologic.com

Full Company Profile

Analyst Forecast

According to 14 analyst ratings, the average rating for HOLX stock is "Hold." The 12-month stock price forecast is $85, which is an increase of 32.70% from the latest price.

Buy 35.71%

Hold 57.14%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Hologic Inc. is scheduled to release its earnings on May 1, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

-10.1%

Hologic shares are trading lower after the company... Unlock content with Pro Subscription

3 months ago

-5.88%

Hologic shares are trading lower. The company reported Q4 financial results.

News

23 hours ago · businesswire.com

Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #aptima--Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay.

1 day ago · finbold.com

Two S&P 500 hidden gems to buy right now

Although the benchmark S&P 500's biggest names tend to dominate investor attention, the index also features lesser-known stocks with significant growth potential.

5 days ago · zacks.com

HOLX's New Offerings Likely to Revive Stock Amid Macro Woes

Hologic's Surgical business has been recording strong broad-based performance by expanding access to technologies into new global markets.

5 days ago · zacks.com

Here's Why You Should Retain HOLX Stock in Your Portfolio Now

Hologic's strength in the molecular diagnostics wing instills optimism among investors. Yet, a dull macroeconomic environment raises concerns.

1 week ago · zacks.com

Deciphering Hologic (HOLX) International Revenue Trends

Examine the evolution of Hologic's (HOLX) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

1 week ago · zacks.com

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

1 week ago · zacks.com

Here's Why Hologic (HOLX) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

1 week ago · zacks.com

Hologic Q1 Earnings Beat, Stock Falls on Dismal '25 Sales Guidance

HOLX's fiscal 2025 first-quarter results reflect the strength of its Molecular Diagnostics business.

1 week ago · seekingalpha.com

Hologic, Inc. (HOLX) Q1 2025 Earnings Call Transcript

Hologic, Inc. (NASDAQ:HOLX ) Q1 2025 Earnings Conference Call February 5, 2025 4:30 PM ET Company Participants Mike Watts - Corporate Vice President, IR Steve MacMillan - Chairman, President and CEO E...

2 weeks ago · zacks.com

Compared to Estimates, Hologic (HOLX) Q1 Earnings: A Look at Key Metrics

The headline numbers for Hologic (HOLX) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estim...

Load More News